Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
作者： Thomas F. Imperiale , David F. Ransohoff , Steven H. Itzkowitz , Barry A. Turnbull , Michael E. Ross
DOI: 10.1056/NEJMOA033403
关键词: Gastroenterology 、 Medicine 、 Population 、 Fecal occult blood 、 Colorectal cancer 、 Asymptomatic 、 Adenocarcinoma 、 Mass screening 、 Risk factor 、 Colonoscopy 、 Internal medicine
摘要: Background Although fecal occult-blood testing is the only available noninvasive screening method that reduces the risk of death from colorectal cancer, it has limited sensitivity. We …
sci-hub.se 参考文章(38)
David F. Ransohoff, Robert S. Sandler, Screening for Colorectal Cancer New England Journal of Medicine. ,vol. 346, pp. 40- 44 ,(2002) , 10.1056/NEJMCP010886
Robert E Schoen, Paul F Pinsky, Joel L Weissfeld, Robert S Bresalier, Timothy Church, Philip Prorok, John K Gohagan, Results of repeat sigmoidoscopy 3 years after a negative examination JAMA. ,vol. 290, pp. 41- 48 ,(2003) , 10.1001/JAMA.290.16.2123-B
Indu B Ahluwalia, Virginia S Bales, Karin A Mack, Wilmon Murphy, Ali H Mokdad, State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001. Morbidity and Mortality Weekly Report. ,vol. 52, pp. 1- 80 ,(2003) , 10.13016/RJHQ-1OLI
David A Lieberman, William V Harford, Dennis J Ahnen, Dawn Provenzale, Stephen J Sontag, Thomas G Schnell, Gregorio Chejfec, Donald R Campbell, Theodore E Durbin, John H Bond, Douglas B Nelson, Stephen L Ewing, George Triadafilopoulos, Francisco C Ramirez, John G Lee, Judith F Collins, M Brian Fennerty, Tiina K Johnston, Christopher L Corless, Kenneth R McQuaid, Harinder Garewal, Richard E Sampliner, Thomas G Morales, Ronnie Fass, Robert E Smith, Yogesh Maheshwari, David G Weiss, None, One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. The New England Journal of Medicine. ,vol. 345, pp. 555- 560 ,(2001) , 10.1056/NEJMOA010328
David A Ahlquist, Anthony P Shuber, Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clinica Chimica Acta. ,vol. 315, pp. 157- 168 ,(2002) , 10.1016/S0009-8981(01)00712-4
Jane F. Desforges, David F. Ransohoff, Christopher A. Lang, Screening for Colorectal Cancer New England Journal of Medicine. ,vol. 325, pp. 37- 41 ,(1991) , 10.1056/NEJM199107043250107
D Sidransky, T Tokino, Hamilton, K. Kinzler, B Levin, P Frost, B Vogelstein, Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. ,vol. 256, pp. 102- 105 ,(1992) , 10.1126/SCIENCE.1566048
S. Thibodeau, G Bren, D Schaid, Microsatellite instability in cancer of the proximal colon Science. ,vol. 260, pp. 816- 819 ,(1993) , 10.1126/SCIENCE.8484122
David F. Ransohoff, CLINICAL GUIDELINE: PART II: Screening for Colorectal Cancer with the Fecal Occult Blood Test: A Background Paper Annals of Internal Medicine. ,vol. 126, pp. 811- 822 ,(1997) , 10.7326/0003-4819-126-10-199705150-00014
David A. Ahlquist, Joel E. Skoletsky, Kevin A. Boynton, Jonathan J. Harrington, Douglas W. Mahoney, William E. Pierceall, Stephen N. Thibodeau, Anthony P. Shuber, Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. ,vol. 119, pp. 1219- 1227 ,(2000) , 10.1053/GAST.2000.19580